tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ESPR Stock Latest News

Esperion secures additional commercial, Medicare formulary coverage for NEXLETOL
The FlyEsperion secures additional commercial, Medicare formulary coverage for NEXLETOL
17d ago
ESPR
Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe)
PremiumPress Releases
Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe)
17d ago
ESPR
Esperion to Participate in Upcoming H.C. Wainwright 26th Annual Global Investment Conference
PremiumPress Releases
Esperion to Participate in Upcoming H.C. Wainwright 26th Annual Global Investment Conference
25d ago
ESPR
Esperion management to meet with Jefferies
PremiumThe Fly
Esperion management to meet with Jefferies
1M ago
ESPR
Options Volatility and Implied Earnings Moves Today, August 12, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, August 12, 2024
1M ago
DHT
RUM
Esperion Reports Second Quarter 2024 Financial Results and Provides a Business Update
PremiumPress ReleasesEsperion Reports Second Quarter 2024 Financial Results and Provides a Business Update
1M ago
ESPR
Esperion reaffirms FY24 revenue view $225M-$245M, consensus $322.41M
Premium
The Fly
Esperion reaffirms FY24 revenue view $225M-$245M, consensus $322.41M
1M ago
ESPR
Esperion reports Q2 EPS (33c), consensus (17c)
Premium
The Fly
Esperion reports Q2 EPS (33c), consensus (17c)
1M ago
ESPR
ESPR Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ESPR Upcoming Earnings Report: What to Expect?
1M ago
ESPR
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PremiumPress Releases
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
1M ago
ESPR
Esperion Announces CMO Transition and Continued Advisory Role
PremiumCompany Announcements
Esperion Announces CMO Transition and Continued Advisory Role
2M ago
8K
ESPR
New Digital First Marketing Campaign from Esperion Alerts Patients with Uncontrolled LDL Cholesterol to the “Lipid Lurkers” Inside Their Arteries
PremiumPress Releases
New Digital First Marketing Campaign from Esperion Alerts Patients with Uncontrolled LDL Cholesterol to the “Lipid Lurkers” Inside Their Arteries
2M ago
ESPR
Esperion announces ‘Lipid Lurkers’ digital first marketing campaign
PremiumThe FlyEsperion announces ‘Lipid Lurkers’ digital first marketing campaign
2M ago
ESPR
Esperion participates in a conference call with Jefferies
Premium
The Fly
Esperion participates in a conference call with Jefferies
2M ago
ESPR
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ESPR
SAVA
Esperion Secures Funding and Clears Debt through Royalty Deal
PremiumCompany Announcements
Esperion Secures Funding and Clears Debt through Royalty Deal
3M ago
8K
ESPR
Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility
PremiumPress Releases
Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility
3M ago
ESPR
Esperion announces it entered into Royalty Purchase Agreement with OMERS
PremiumThe Fly
Esperion announces it entered into Royalty Purchase Agreement with OMERS
3M ago
ESPR
Buy/Sell: Wall Street’s top 10 stock calls this week
PremiumThe Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
3M ago
KR
ACI
Spirit Aero downgraded, Skyworks upgraded: Wall Street’s top analyst calls
PremiumThe FlySpirit Aero downgraded, Skyworks upgraded: Wall Street’s top analyst calls
3M ago
BA
BFH
Esperion downgraded to Underperform from Neutral at BofA
Premium
The Fly
Esperion downgraded to Underperform from Neutral at BofA
3M ago
MRK
ESPR
Esperion Stockholders Approve Key Proposals at Annual Meeting
Premium
Company Announcements
Esperion Stockholders Approve Key Proposals at Annual Meeting
4M ago
8K
ESPR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >